CASC4/GOLM2 drives high grade serous carcinoma anoikis resistance through the recycling of EGFR
Cancer Gene Therapy, Published online: 29 November 2023; doi:10.1038/s41417-023-00703-1CASC4/GOLM2 drives high grade serous carcinoma anoikis resistance through the recycling of EGFR (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - November 29, 2023 Category: Cancer & Oncology Authors: Jaidev Bapat Tomomi M. Yamamoto Elizabeth R. Woodruff Lubna Qamar Railey G. Mikeska Katherine M. Aird Zachary L. Watson Lindsay W. Brubaker Benjamin G. Bitler Source Type: research
METTL3 facilitates stemness properties and tumorigenicity of cancer stem cells in hepatocellular carcinoma through the SOCS3/JAK2/STAT3 signaling pathway
Cancer Gene Therapy, Published online: 29 November 2023; doi:10.1038/s41417-023-00697-wMETTL3 facilitates stemness properties and tumorigenicity of cancer stem cells in hepatocellular carcinoma through the SOCS3/JAK2/STAT3 signaling pathway (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - November 29, 2023 Category: Cancer & Oncology Authors: Jingjing Hu Ke Chen Fangfang Hong Guosheng Gao Xiaoyu Dai Hua Yin Source Type: research
Novel biomarker SARIFA in colorectal cancer: highly prognostic, not genetically driven and histologic indicator of a distinct tumor biology
Cancer Gene Therapy, Published online: 22 November 2023; doi:10.1038/s41417-023-00695-yNovel biomarker SARIFA in colorectal cancer: highly prognostic, not genetically driven and histologic indicator of a distinct tumor biology (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - November 22, 2023 Category: Cancer & Oncology Authors: Nic G. Reitsam Veselin Grozdanov Chiara M. L. L öffler Hannah S. Muti Bianca Grosser Jakob N. Kather Bruno M ärkl Source Type: research
Chimeric TβRII-SE/Fc overexpression by a lentiviral vector exerts strong antitumoral activity on colorectal cancer-derived cell lines in vitro and on xenografts
Cancer Gene Therapy, Published online: 22 November 2023; doi:10.1038/s41417-023-00694-zChimeric TβRII-SE/Fc overexpression by a lentiviral vector exerts strong antitumoral activity on colorectal cancer-derived cell lines in vitro and on xenografts (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - November 22, 2023 Category: Cancer & Oncology Authors: Ana Romo Tania Melina Rodr íguez Guo Yu Ricardo Alfredo Dewey Source Type: research
TNFRSF19 promotes endoplasmic reticulum stress-induced paraptosis via the activation of the MAPK pathway in triple-negative breast cancer cells
Cancer Gene Therapy, Published online: 21 November 2023; doi:10.1038/s41417-023-00696-xTNFRSF19 promotes endoplasmic reticulum stress-induced paraptosis via the activation of the MAPK pathway in triple-negative breast cancer cells (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - November 21, 2023 Category: Cancer & Oncology Authors: Shiyang Liu Yao Tian Chenguang Liu Zhengwei Gui Tianyao Yu Lin Zhang Source Type: research
Cell fusion upregulates PD-L1 expression for evasion from immunosurveillance
Cancer Gene Therapy, Published online: 21 November 2023; doi:10.1038/s41417-023-00693-0Cell fusion upregulates PD-L1 expression for evasion from immunosurveillance (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - November 21, 2023 Category: Cancer & Oncology Authors: Youichi Tajima Futoshi Shibasaki Hisao Masai Source Type: research
Downstream STING pathways IRF3 and NF-κB differentially regulate CCL22 in response to cytosolic dsDNA
Cancer Gene Therapy, Published online: 21 November 2023; doi:10.1038/s41417-023-00678-zDownstream STING pathways IRF3 and NF-κB differentially regulate CCL22 in response to cytosolic dsDNA (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - November 21, 2023 Category: Cancer & Oncology Authors: Jihyun Kim Jocelyn V. Pena Hannah P. McQueen Lingwei Kong Dina Michael Elmira M. Lomashvili Pamela R. Cook Source Type: research
IGH repertoire analysis at scale: deciphering the complexity of B cell infiltration and migration in esophageal squamous cell carcinoma
Cancer Gene Therapy, Published online: 20 November 2023; doi:10.1038/s41417-023-00689-wIGH repertoire analysis at scale: deciphering the complexity of B cell infiltration and migration in esophageal squamous cell carcinoma (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - November 20, 2023 Category: Cancer & Oncology Authors: Longlong Wang Yong Zhou Heyang Cui Xuehan Zhuang Chen Cheng Yongjia Weng Huijuan Liu Shubin Wang Xinghua Pan Yongping Cui Weimin Zhang Source Type: research
Arvanil induces ferroptosis of hepatocellular carcinoma by binding to MICU1
Cancer Gene Therapy, Published online: 20 November 2023; doi:10.1038/s41417-023-00690-3Arvanil induces ferroptosis of hepatocellular carcinoma by binding to MICU1 (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - November 20, 2023 Category: Cancer & Oncology Authors: Xiangying Deng Yajun Gui Lin Zhao Namei Li Liling Li Source Type: research
Research progress and application of single-cell sequencing in head and neck malignant tumors
Cancer Gene Therapy, Published online: 15 November 2023; doi:10.1038/s41417-023-00691-2Research progress and application of single-cell sequencing in head and neck malignant tumors (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - November 15, 2023 Category: Cancer & Oncology Authors: Siyuan Qu Mengdan Gong Yongqin Deng Yizhen Xiang Dong Ye Source Type: research
CILP is a potential pan-cancer marker: combined silico study and in vitro analyses
Cancer Gene Therapy, Published online: 15 November 2023; doi:10.1038/s41417-023-00688-xCILP is a potential pan-cancer marker: combined silico study and in vitro analyses (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - November 15, 2023 Category: Cancer & Oncology Authors: Bingjie Guo Feiran Zhao Sailong Zhang Source Type: research
STK11 loss leads to YAP1-mediated transcriptional activation in human KRAS-driven lung adenocarcinoma cell lines
Cancer Gene Therapy, Published online: 15 November 2023; doi:10.1038/s41417-023-00687-ySTK11 loss leads to YAP1-mediated transcriptional activation in human KRAS-driven lung adenocarcinoma cell lines (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - November 15, 2023 Category: Cancer & Oncology Authors: Sean M. Lenahan Hailey M. Sarausky Paula Deming David J. Seward Source Type: research
Correction: The KRAS-G12C inhibitor: activity and resistance
Cancer Gene Therapy, Published online: 15 November 2023; doi:10.1038/s41417-023-00692-1Correction: The KRAS-G12C inhibitor: activity and resistance (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - November 15, 2023 Category: Cancer & Oncology Authors: Jiao Liu Rui Kang Daolin Tang Source Type: research
Boosting cytotoxicity of adoptive allogeneic NK cell therapy with an oncolytic adenovirus encoding a human vIL-2 cytokine for the treatment of human ovarian cancer
Cancer Gene Therapy, Published online: 10 November 2023; doi:10.1038/s41417-023-00674-3Boosting cytotoxicity of adoptive allogeneic NK cell therapy with an oncolytic adenovirus encoding a human vIL-2 cytokine for the treatment of human ovarian cancer (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - November 10, 2023 Category: Cancer & Oncology Authors: D. C. A. Quixabeira S. Pakola E. Jirovec R. Havunen S. Basnet J. M. Santos T. V. Kudling J. H. A. Clubb L. Haybout V. Arias S. Gr önberg-Vähä-Koskela V. Cervera-Carrascon E. Kerkel ä A. Pasanen M. Anttila J. Tapper A. Kanerva A. Hemminki Source Type: research
MBD1 protects replication fork stability by recruiting PARP1 and controlling transcription-replication conflicts
Cancer Gene Therapy, Published online: 10 November 2023; doi:10.1038/s41417-023-00685-0MBD1 protects replication fork stability by recruiting PARP1 and controlling transcription-replication conflicts (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - November 10, 2023 Category: Cancer & Oncology Authors: Guihui Yu Yundong Xiong Zhanzhan Xu Lei Zhang Xiao Albert Zhou Chen Nie Shiwei Li Weibin Wang Xiaoman Li Jiadong Wang Source Type: research
